SteadyMD Alternatives for Telehealth Brands

What problem should a SteadyMD alternative solve?

SteadyMD’s API materials describe limited integration using the partner’s EMR and complete integration using SteadyMD’s EMR. That architecture choice matters. A buyer searching for alternatives may be dissatisfied with capacity, integration, workflow or the surrounding commercial operation; each issue points toward a different evaluation.

Start by naming the missing capability. If you already have the product and care-management operation, a clinical workforce or API option may be appropriate. If you want to launch an own-brand service with payments, subscriptions and customer support, compare a broader scope. The TEHR versus SteadyMD comparison explains the documented boundaries.

Do not use a feature checklist to obscure who will do the work. A platform can expose a useful API while your team remains responsible for building the patient experience, staffing administrative support and resolving exceptions. A proposal is useful when it identifies those responsibilities and the dependencies between them.

Which operating models belong on the shortlist?

This shortlist groups different operating models. The order is editorial, with TEHR first, and does not represent independent testing or numerical scores. Vendor statements are presented as of October 22, 2026; a missing public detail means it needs confirmation, not that the capability is absent.

When is TEHR the right alternative to evaluate?

TEHR combines white-label technology and administrative infrastructure with an independent licensed clinical network reaching all 50 states, subject to program, state and patient eligibility. It supports clinician e-prescribing, pharmacy coordination, AI-assisted intake, payments and subscriptions. Clinical decisions remain with independent licensed providers. Its commercial model is a flat platform subscription plus flat transaction fee and 0% revenue share; contact TEHR for a scoped quote. See the platform and pricing scope.

TEHR is worth evaluating when the objective extends from clinical capacity to operating a commercial health brand. Its technology and administrative offering includes payments and subscriptions connected to independent clinical services. Ask what would change in the existing EMR, patient portal and support workflow. The operator-led approach is relevant only if its proposed scope solves the actual problem your team has identified.

Trade-off: Confirm the actual clinical, pharmacy, support and integration scope before treating a platform proposal as an all-inclusive service. Patients see the brand, while required notices still identify the real care entities. Selected peptide programs are pending and are not open for prescribing or fulfillment.

When should you consider Wheel?

Strength: Wheel’s Horizon offering combines a configurable platform, clinician network and clinical operations. Its launch page describes an EMR, branded patient experience and modular programs; connected services include prescription fulfillment, pharmacy delivery and laboratory connections. Official launch virtual care; Connected services.

Consider Wheel when you want a configured care program with a patient experience and connected services alongside the clinician network. Compare the exact package with the SteadyMD architecture you would otherwise use. A broader platform may change more of the operation, so account for implementation and retained systems.

Trade-off: The reviewed public pages do not establish universal numeric pricing or revenue-share terms. Ask how the exact channel, program, patient experience and service connections are packaged. A connection to a service does not necessarily include the cost of using that service.

When should you consider Beluga Health?

Strength: Beluga offers direct API, hosted intake and platform-partner configurations. Its pricing page explicitly describes no cut of customer revenue, flat monthly access, per-visit fees and pharmacy/lab pass-through with disclosed service charges. Dollar amounts are quoted during scoping. Official platform integration paths; Pricing.

Consider Beluga when you want to keep the commercial experience and use a modular physician-led backend. Map the responsibilities of any platform partner separately. This can suit a capable technical team, but it should not be presented as a complete replacement for administrative functions unless those services are explicitly included.

Trade-off: Determine which company supplies commerce, subscriptions and patient support in your chosen configuration. A clinical backend can be the right fit for an existing stack, but its fee alone should not be compared with the price of a complete commercial operation.

When should you consider MD Integrations?

Strength: MD Integrations describes a physician-only network and both API and ready-made patient workflows. Its FAQ covers pharmacy fulfillment and tailored pricing, and explicitly states that it does not prescribe controlled substances. That limitation matters when evaluating a proposed hormone program. Official platform and physician network; FAQ.

Consider MD Integrations when physician-only staffing is a desired configuration and the intended programs fit its public scope. Its controlled-substance policy is a useful early filter. Ask for a representative clinical workflow and confirm pricing before assuming its API route and your current integration are interchangeable.

Trade-off: Do not infer testosterone prescribing from a broad hormone or men’s-health category. Confirm program eligibility and the exact commercial scope before integrating. The reviewed sources do not establish a standard patient-migration service or a universal numerical rate card.

When should you consider OpenLoop?

Strength: OpenLoop’s Launchpad describes a no-code website, branded portal, intake, clinicians and operating workflows. The current product is broader than a clinician network; its official page also describes integration into existing customer systems. Official launchpad and platform.

Consider OpenLoop when the objective is a broader brand operation rather than only a different workforce connection. Launchpad’s public scope includes storefront and operational components. Identify what that would replace in your existing environment and what benefit the change produces before adding a full-platform migration to a staffing decision.

Trade-off: The reviewed page does not establish a universal numeric rate card or revenue-share policy. Request itemized terms and identify the work your team retains. Treat its fastest launch statement as a vendor estimate with readiness conditions, not a migration guarantee.

When should you consider Lithos Health?

Strength: Lithos describes a white-label medical practice delivered through an API while customers build their own product. Its pricing page publishes per-completed-visit bands, and its migration page describes staged transitions with parallel testing and clinical continuity work. Official practice infrastructure; Pricing.

Consider Lithos when your product team wants a clinical practice API and can continue owning the customer experience. Its public visit pricing and migration process can support a more concrete evaluation. Model the appropriate modality and volume bands, and keep product development and support costs in the decision.

Trade-off: The brand must account for building and operating the customer-facing product. Compare the appropriate modality and graduated volume bands, not only the lowest advertised visit rate. Public migration guidance is useful, but your source records and program still determine the plan. Migration.

When should you consider CareValidate?

Strength: CareValidate describes integrated white-label infrastructure and a nationwide provider network. Its laboratory page outlines both at-home kits and in-person orders, with results connected to charts and provider workflows. Its launch materials describe managed patient support and existing-stack API connectivity. Official provider network; Labs and diagnostics.

Consider CareValidate when the intended operation includes integrated diagnostics, fulfillment and administrative support. Its laboratory descriptions offer specific handoffs to inspect. Ask how data returns to the clinical workflow and how the patient receives instructions, then confirm the complete service and commercial scope in writing.

Trade-off: Request an itemized fee schedule and migration scope; neither was established on the reviewed public pages. Confirm which support tasks and lab costs are included. A broadly integrated offering still needs a clear handoff when a patient needs clinical rather than administrative help. Launch telehealth.

When should you consider Healthie?

Strength: Healthie offers practice software; full web white-label is an Enterprise add-on. Its documentation describes patient import, with scope varying by plan. Entry-level software prices are not the price of an Enterprise white-label configuration or a supplied nationwide clinical workforce. Official full web white-label; Client data import.

Consider Healthie when your organization already has clinicians and the principal requirement is practice-management or patient-engagement software. This is an adjacent option rather than a verified supplied-workforce substitute. Confirm Enterprise white-label scope and migration depth, and separately account for any clinical services the business still needs.

Trade-off: Evaluate it as software for your clinical operation unless a separate proposal establishes more. Identify who supplies clinicians, pharmacy fulfillment and support before comparing the invoice with an integrated telehealth service. A demographic import is not equivalent to a complete clinical migration.

How should you narrow the shortlist?

Build three requirement columns: clinical capacity, clinical workflow and commercial operation. Put each problem in one column before asking vendors to respond. Examples include the need for a particular clinician role, a clearer results-review process, or better subscription administration. Some projects touch all three, but the distinction prevents a broad software change from being justified by a narrow issue.

Give each finalist the same scenario and ask where the work occurs. Which record is authoritative? Which team contacts the patient? How is a clinical change reflected in the subscription system? What happens when an integration fails? Record the proposed owner of each action instead of accepting a generic assurance that the systems connect.

Review TEHR pricing alongside complete alternative proposals. Include your retained EMR, patient experience, staff and third-party services. The best architecture may preserve much of your current investment; it may also consolidate responsibilities. The cost model should reflect the chosen design.

How should existing patients move to the chosen platform?

If the EMR remains in place, the transition may focus on clinician access, routing and handoffs. If a new clinical record system is introduced, the project also needs chart validation, consent handling and identity reconciliation. Those should be separate workstreams rather than a single generic import task.

Use the migration checklist to test a continuing patient’s next encounter and follow-up. Do not infer a complete migration offering from an API that creates a patient record. Ask for a scoped process, ownership of unresolved cases and a plan that prevents the technical cutover from interrupting clinical responsibility.

What should the final proposal make explicit?

Ask for the service boundaries, itemized charges, implementation dependencies and operational acceptance criteria in writing. Review the white-label telehealth guide if the proposals use the same label for different scopes, and use the resource library to prepare program and migration questions. A good shortlist should become a small set of comparable proposals. It should not end as a ranking that hides unanswered questions about who supplies care, who performs administrative work and what the brand will actually pay.

For a wider category view, compare the white-label telehealth platform shortlist and the turnkey telehealth platform shortlist. Use the first to examine brand and architecture choices, and the second to assess which implementation and operating tasks a proposed package actually supplies.

What else should you know?